Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study: Palivizumab prophylaxis in children with congenital heart disease

BACKGROUND: In children with congenital heart disease (CHD) respiratory syncytial virus (RSV) infection may have a severe course, with increased risk of morbidity and mortality, requiring hospital admission and intensive care. The aim of the present study was to evaluate the effect of prophylaxis wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratti, Chiara, Greca, Anna della, Bertoncelli, Deborah, Rubini, Monica, Tchana, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835345/
https://www.ncbi.nlm.nih.gov/pubmed/36631870
http://dx.doi.org/10.1186/s13052-022-01399-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835345/
https://www.ncbi.nlm.nih.gov/pubmed/36631870
http://dx.doi.org/10.1186/s13052-022-01399-z

Ejemplares similares